Yarbrough Capital’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Yarbrough Capital’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-76,872	Closed	-$1.64M	–	206
2024 Q1	$1.64M	Hold	76,872	–	–	0.07%	77
2023 Q4	$739K	Buy	+76,872	New	+$374K	0.04%	105

Yarbrough Capital's FUSN Position: Q2 2024 in Review

Yarbrough Capital sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 76,872 shares — an estimated $1.64M sold.

Yarbrough Capital first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $1.64M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Yarbrough Capital reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Yarbrough Capital sold 76,872 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.64M.
Yarbrough Capital first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Yarbrough Capital's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.64M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Yarbrough Capital's 13F filing for Q2 2024, filed 17 Jul 2024.